CompoAtlas

Colpropur immuno protect saveur neutre

Food supplement declared in France, declaration No 2021-2-506, decision dated 9 February 2021

Colpropur immuno protect saveur neutre (Colpropur) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Colpropur
Food business operator placing the product on the market
PROTEIN SA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
10,3 grammes
Directions for use
prendre 1 dose de 10,3 grammes par jour via doseur intégré
Not recommended for (according to the manufacturer)
Insuffisance rénale, Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Articulations, Immunité
Flavourings
neutre

Declaration 336366, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Other active ingredients

NamePer day
Collagène hydrolysénot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Citrate de cuivreCuivre5,000 µg2,000 µg
Pyrophosphate ferriqueFer40 mg (niveau de sécurité)14 mg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Levure enrichie en séléniumSélénium255 µg50 µg
Acétate de rétinyleVitamine A3,000 µg d'équivalent rétinol800 µg
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
L-ascorbate de calciumVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Gluconate de zincZinc25 mg15 mg

Additives

E960

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les personnes qui nécessitent un régime restreint en protéines (insuffisance rénale ou hépatique grave) doivent prendre ce produit sous surveillance médicale. Ne convient pas aux phénylcétoruniques

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Collagène hydrolysé
    Read the warning, when it applies and the studies cited

    Hydrolyzed Collagen

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Applies to products providing more than 2.8 g hydrolyzed collagen, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Colpropur

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line